Guidelines for the standard monitoring of patients with thalassemia

Report of the thalassemia longitudinal cohort

Venée N. Tubman, Ellen B. Fung, Maria Vogiatzi, Alexis A Thompson, Zora R. Rogers, Ellis J. Neufeld, Janet L. Kwiatkowski*

*Corresponding author for this work

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Chronic transfusion therapy has played a central role in extending life expectancy for patients with hemoglobinopathies such as thalassemia. However, this life-saving therapy is associated with numerous complications that now comprise the bulk of management considerations for patients with thalassemia. This review reports on the experience of the Thalassemia Longitudinal Cohort and reviews available literature to establish guidelines for the management of patients with thalassemia.

Original languageEnglish (US)
Pages (from-to)e162-e169
JournalJournal of Pediatric Hematology/Oncology
Volume37
Issue number3
DOIs
StatePublished - Jan 1 2015

Fingerprint

Thalassemia
Physiologic Monitoring
Guidelines
Hemoglobinopathies
Life Expectancy
Therapeutics

Keywords

  • endocrinopathy
  • iron overload
  • thalassemia
  • transfusion
  • treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Tubman, Venée N. ; Fung, Ellen B. ; Vogiatzi, Maria ; Thompson, Alexis A ; Rogers, Zora R. ; Neufeld, Ellis J. ; Kwiatkowski, Janet L. / Guidelines for the standard monitoring of patients with thalassemia : Report of the thalassemia longitudinal cohort. In: Journal of Pediatric Hematology/Oncology. 2015 ; Vol. 37, No. 3. pp. e162-e169.
@article{a7f899bc111b4c5789a327da085ac6b3,
title = "Guidelines for the standard monitoring of patients with thalassemia: Report of the thalassemia longitudinal cohort",
abstract = "Chronic transfusion therapy has played a central role in extending life expectancy for patients with hemoglobinopathies such as thalassemia. However, this life-saving therapy is associated with numerous complications that now comprise the bulk of management considerations for patients with thalassemia. This review reports on the experience of the Thalassemia Longitudinal Cohort and reviews available literature to establish guidelines for the management of patients with thalassemia.",
keywords = "endocrinopathy, iron overload, thalassemia, transfusion, treatment",
author = "Tubman, {Ven{\'e}e N.} and Fung, {Ellen B.} and Maria Vogiatzi and Thompson, {Alexis A} and Rogers, {Zora R.} and Neufeld, {Ellis J.} and Kwiatkowski, {Janet L.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1097/MPH.0000000000000307",
language = "English (US)",
volume = "37",
pages = "e162--e169",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Guidelines for the standard monitoring of patients with thalassemia : Report of the thalassemia longitudinal cohort. / Tubman, Venée N.; Fung, Ellen B.; Vogiatzi, Maria; Thompson, Alexis A; Rogers, Zora R.; Neufeld, Ellis J.; Kwiatkowski, Janet L.

In: Journal of Pediatric Hematology/Oncology, Vol. 37, No. 3, 01.01.2015, p. e162-e169.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Guidelines for the standard monitoring of patients with thalassemia

T2 - Report of the thalassemia longitudinal cohort

AU - Tubman, Venée N.

AU - Fung, Ellen B.

AU - Vogiatzi, Maria

AU - Thompson, Alexis A

AU - Rogers, Zora R.

AU - Neufeld, Ellis J.

AU - Kwiatkowski, Janet L.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Chronic transfusion therapy has played a central role in extending life expectancy for patients with hemoglobinopathies such as thalassemia. However, this life-saving therapy is associated with numerous complications that now comprise the bulk of management considerations for patients with thalassemia. This review reports on the experience of the Thalassemia Longitudinal Cohort and reviews available literature to establish guidelines for the management of patients with thalassemia.

AB - Chronic transfusion therapy has played a central role in extending life expectancy for patients with hemoglobinopathies such as thalassemia. However, this life-saving therapy is associated with numerous complications that now comprise the bulk of management considerations for patients with thalassemia. This review reports on the experience of the Thalassemia Longitudinal Cohort and reviews available literature to establish guidelines for the management of patients with thalassemia.

KW - endocrinopathy

KW - iron overload

KW - thalassemia

KW - transfusion

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=84926360766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926360766&partnerID=8YFLogxK

U2 - 10.1097/MPH.0000000000000307

DO - 10.1097/MPH.0000000000000307

M3 - Article

VL - 37

SP - e162-e169

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 3

ER -